Literature DB >> 9696626

Occurrence and significance of atypical Aeromonas salmonicida in non-salmonid and salmonid fish species: a review.

T Wiklund1, I Dalsgaard.   

Abstract

Bacterial strains of Aeromonas salmonicida included in the recognized subsp. acromogenes, subsp. masoucida, and subsp. smithia in addition to the large number of strains not included in any of the described subspecies are referred to as atypical A. salmonicida. The atypical strains form a very heterogeneous group with respect to biochemical characteristics, growth conditions, and production of extracellular proteasess. Consequently, the present taxonomy of the species A. salmonicida is rather ambiguous. Atypical A. salmonicida has been isolated from a wide range of cultivated and wild fish species, non-salmonids as well as salmonids, inhabiting fresh water, brackish water and marine environments in northern and central Europe, South Africa, North America, Japan and Australia. In non-salmonid fish species, infections with atypical strains often manifest themselves as superficial skin ulcerations. The best known diseases associated with atypical A. salmonicida are carp Cyprinus carpio erythrodermatitis, goldfish Carassius auratus ulcer disease, and ulcer disease of flounder Platichthys flesus, but atypical strains are apparently involved in more disease outbreaks than previously suspected. Macroscopical and microscopical studies of ulcerated fish indicate internal organs are infrequently invaded by atypical A. salmonicida. This view is supported by the fact that atypical strains are irregularly isolated from visceral organs of ulcerated fish. High mortality caused by atypical A. salmonicida has been observed in populations of wild non-salmonids and farmed salmonids, although the association between the mortality in the wild fish stocks and atypical A. salmonicida has not always been properly assessed. In injection experiments the pathogenicity of the atypical strains examined showed large variation. An extacellular A-layer has been detected in different atypical strains, but virulence mechanisms different from those described for (typical) A. salmonicida subsp. salmonicida, for example an extracellular metallo-protease and a different iron utilization mechanism, have been described. Limited information is available about the ecology, spread and survival of atypical strains in water. The commonly used therapeutic methods for the control of diseases in farmed fish caused by atypical A. salmonicida are generally effective against the atypical strains. Resistance to different antibiotics and transferable plasmid encoding multiple drug resistance have been observed in atpical A. salmonicida. Studies aimed at producing a vaccine against atypical strains are in progress.

Entities:  

Mesh:

Year:  1998        PMID: 9696626     DOI: 10.3354/dao032049

Source DB:  PubMed          Journal:  Dis Aquat Organ        ISSN: 0177-5103            Impact factor:   1.802


  26 in total

1.  Isolation and characterization of a lytic Myoviridae bacteriophage PAS-1 with broad infectivity in Aeromonas salmonicida.

Authors:  J H Kim; J S Son; Y J Choi; C H Choresca; S P Shin; J E Han; J W Jun; D H Kang; C Oh; S J Heo; S C Park
Journal:  Curr Microbiol       Date:  2012-05       Impact factor: 2.188

2.  Detection of the causative agent of furunculusis, Aeromonas salmonicida in salmonids of the Krka River.

Authors:  D Kapetanović; I Vardić; B Kurtović; D Valić; E Teskeredzić
Journal:  Vet Res Commun       Date:  2007-07-11       Impact factor: 2.459

Review 3.  Immunological control of fish diseases.

Authors:  Bergljot Magnadottir
Journal:  Mar Biotechnol (NY)       Date:  2010-03-30       Impact factor: 3.619

4.  Draft genome sequence of the virulent strain 01-B526 of the fish pathogen Aeromonas salmonicida.

Authors:  Steve J Charette; Francis Brochu; Brian Boyle; Geneviève Filion; Katherine H Tanaka; Nicolas Derome
Journal:  J Bacteriol       Date:  2012-02       Impact factor: 3.490

5.  Aeromonas salmonicida Growth in Response to Atlantic Salmon Mucins Differs between Epithelial Sites, Is Governed by Sialylated and N-Acetylhexosamine-Containing O-Glycans, and Is Affected by Ca2.

Authors:  János Tamás Padra; Henrik Sundh; Kristina Sundell; Vignesh Venkatakrishnan; Chunsheng Jin; Tore Samuelsson; Niclas G Karlsson; Sara K Lindén
Journal:  Infect Immun       Date:  2017-07-19       Impact factor: 3.441

6.  Determination of microbial diversity of Aeromonas strains on the basis of multilocus sequence typing, phenotype, and presence of putative virulence genes.

Authors:  Maria Elena Martino; Luca Fasolato; Filomena Montemurro; Marina Rosteghin; Amedeo Manfrin; Tomaso Patarnello; Enrico Novelli; Barbara Cardazzo
Journal:  Appl Environ Microbiol       Date:  2011-06-03       Impact factor: 4.792

7.  Molecular basis of sulfonamide and trimethoprim resistance in fish-pathogenic Aeromonas isolates.

Authors:  Kristina Kadlec; Ellen von Czapiewski; Heike Kaspar; Jürgen Wallmann; Geovana Brenner Michael; Ulrike Steinacker; Stefan Schwarz
Journal:  Appl Environ Microbiol       Date:  2011-07-15       Impact factor: 4.792

8.  Isolation and Characterization of Multidrug Resistance Aeromonas salmonicida subsp. salmonicida and Its Infecting Novel Phage ASP-1 from Goldfish (Carassius auratus).

Authors:  Chamilani Nikapitiya; S H S Dananjaya; H P S U Chandrarathna; Amal Senevirathne; Mahanama De Zoysa; Jehee Lee
Journal:  Indian J Microbiol       Date:  2019-02-04       Impact factor: 2.461

9.  Induction of IL-22 protein and IL-22-producing cells in rainbow trout Oncorhynchus mykiss.

Authors:  Yehfang Hu; Yamila Carpio; Callum Scott; Ayham Alnabulsi; Abdo Alnabulsi; Tingyu Wang; Fuguo Liu; Milena Monte; Tiehui Wang; Christopher J Secombes
Journal:  Dev Comp Immunol       Date:  2019-07-12       Impact factor: 3.636

10.  Aeromonas salmonicida binds differentially to mucins isolated from skin and intestinal regions of Atlantic salmon in an N-acetylneuraminic acid-dependent manner.

Authors:  János T Padra; Henrik Sundh; Chunsheng Jin; Niclas G Karlsson; Kristina Sundell; Sara K Lindén
Journal:  Infect Immun       Date:  2014-10-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.